Results 321 to 330 of about 775,077 (341)
Some of the next articles are maybe not open access.
Atherosclerosis and thrombosis
2015Atherosclerosis is the main underlying cause of heart disease. The continuous exposure to cardiovascular risk factors induces endothelial activation/dysfunction which enhances the permeability of the endothelial layer and the expression of cytokines/chemokines and adhesion molecules.
Gemma Vilahur, Lina Badimon
openaire +1 more source
Hyperhomocysteinemia and thrombosis
Lipids, 2001AbstractHomocysteine (Hcy) is a sulfhydryl amino acid derived from the metabolic conversion of methionine, which is dependent on vitamins (folic acid, B12, and B6) as cofactors or cosubstrates. In 1969, McCully first reported the presence of severe atherosclerotic lesions in patients with severe hyperhomocysteinemia and hypothesized the existence of a ...
openaire +4 more sources
Diseases of the Colon & Rectum, 1988
Two patients who had suffered numerous previous attacks of perianal hematoma were treated by excision of the lesions and adjacent skin (low hemorrhoidectomy). Histology confirmed that these lesions are not hematomas but thrombi lying within the thin-walled vessels of the external anal plexus.
Rober Brearley, Stephen Brearley
openaire +3 more sources
Two patients who had suffered numerous previous attacks of perianal hematoma were treated by excision of the lesions and adjacent skin (low hemorrhoidectomy). Histology confirmed that these lesions are not hematomas but thrombi lying within the thin-walled vessels of the external anal plexus.
Rober Brearley, Stephen Brearley
openaire +3 more sources
Critical Reviews in Oncology/Hematology, 1989
This review addresses the question of the involvement of fibrin in the development of atherosclerotic plaques. Numerous studies in the older literature demonstrated the presence of fibrinogen and/or fibrin in plaques, but the techniques that were available (mainly immunochemistry and immunohistochemistry with polyclonal antifibrinogen antibodies) did ...
Karen L. Kaplan +3 more
openaire +2 more sources
This review addresses the question of the involvement of fibrin in the development of atherosclerotic plaques. Numerous studies in the older literature demonstrated the presence of fibrinogen and/or fibrin in plaques, but the techniques that were available (mainly immunochemistry and immunohistochemistry with polyclonal antifibrinogen antibodies) did ...
Karen L. Kaplan +3 more
openaire +2 more sources
2015
Antithrombotic therapy consisting of antiplatelet agents and/or anticoagulants is an important way to avoid atherothrombotic complications, especially in secondary prevention. Primary prevention by antithrombotic measures usually refers to the prevention of stroke in patients with atrial fibrillation and an increased risk for stroke or peripheral ...
Joao Morais, Kurt Huber
openaire +1 more source
Antithrombotic therapy consisting of antiplatelet agents and/or anticoagulants is an important way to avoid atherothrombotic complications, especially in secondary prevention. Primary prevention by antithrombotic measures usually refers to the prevention of stroke in patients with atrial fibrillation and an increased risk for stroke or peripheral ...
Joao Morais, Kurt Huber
openaire +1 more source
Human Pathology, 1987
Abnormal hemostasis is a fundamental property of malignant disease, not merely an epiphenomenon attributable to therapy or to chronic illness. Many types of tumor cells express clotting initiators such as tissue factor and act again late in the coagulation pathway by providing a surface for prothrombinase generation. Thus, entry of tumor cells into the
openaire +3 more sources
Abnormal hemostasis is a fundamental property of malignant disease, not merely an epiphenomenon attributable to therapy or to chronic illness. Many types of tumor cells express clotting initiators such as tissue factor and act again late in the coagulation pathway by providing a surface for prothrombinase generation. Thus, entry of tumor cells into the
openaire +3 more sources
Best Practice & Research Clinical Haematology, 1999
The fibrinolytic system generates plasmin, which dissolves fibrin in haemostatic plugs and in thrombi. It is often regarded simply as a secondary phenomenon responsive to the generation of thrombi but it is, rather, in dynamic balance with fibrin formation, such that abnormalities in either can lead to thrombosis.
openaire +3 more sources
The fibrinolytic system generates plasmin, which dissolves fibrin in haemostatic plugs and in thrombi. It is often regarded simply as a secondary phenomenon responsive to the generation of thrombi but it is, rather, in dynamic balance with fibrin formation, such that abnormalities in either can lead to thrombosis.
openaire +3 more sources
Pathophysiology of Haemostasis and Thrombosis, 1994
Thrombosis is the most frequent complication and the second cause of death in patients with overt malignant disease. Increasing evidence suggests that thrombotic episodes may also precede the diagnosis of cancer by months or years thus representing a potential marker for occult malignancy.
openaire +3 more sources
Thrombosis is the most frequent complication and the second cause of death in patients with overt malignant disease. Increasing evidence suggests that thrombotic episodes may also precede the diagnosis of cancer by months or years thus representing a potential marker for occult malignancy.
openaire +3 more sources